I now have excellent source material from Robbins Basic Pathology and Robbins & Cotran Pathologic Basis of Disease. I have enough information to write comprehensive, high-yield exam notes. Let me compile everything now.
General Pathology - High-Yield Exam Notes
Based on Robbins Basic Pathology & Robbins & Cotran Pathologic Basis of Disease
PART 1: CELL INJURY, CELL DEATH & ADAPTATIONS
Key Definitions
- Etiology - the cause/origin of a disease (the "why")
- Pathogenesis - the steps/mechanisms by which disease develops (the "how")
- Morphology - the structural changes in cells/tissues that characterize a disease
Cellular Responses to Stress (in order of severity)
| Stress Level | Cell Response |
|---|
| Mild / reversible stress | Adaptation (hypertrophy, hyperplasia, atrophy, metaplasia) |
| Moderate | Reversible injury |
| Severe / prolonged | Irreversible injury → Cell Death (necrosis or apoptosis) |
Causes of Cell Injury (HIGH YIELD)
- Hypoxia & Ischemia - most common; deprive cells of oxygen (ATP depletion is the key event)
- Physical agents - trauma, extreme temperature, radiation, electric shock
- Chemical agents & drugs - poisons, pollutants, therapeutic drugs
- Infectious agents - viruses, bacteria, fungi, parasites
- Immunologic reactions - autoimmune disease, hypersensitivity
- Genetic defects - mutations causing protein dysfunction
- Nutritional imbalances - deficiencies or excess
Reversible vs Irreversible Injury
| Feature | Reversible | Irreversible |
|---|
| Hallmark | Cell swelling, fatty change | Membrane damage, lysosomal rupture |
| Mitochondria | Swollen, amorphous densities | Flocculent densities |
| Key event | ATP depletion | Ca²⁺ influx + membrane destruction |
| Outcome | Cell recovers | Necrosis or apoptosis |
Mechanisms of Cell Injury - The "Big 5"
- Mitochondrial dysfunction - ATP depletion → Na⁺/K⁺ pump fails → cell swelling
- Oxidative stress (ROS) - damage to DNA, lipids, proteins; generated by reperfusion, drugs, radiation
- Membrane damage - lysosomal leakage, mitochondrial permeability, plasma membrane damage
- Calcium influx - activates destructive enzymes (phospholipases, proteases, endonucleases, ATPases)
- DNA damage / ER stress - misfolded proteins trigger cell death pathways
Necrosis vs Apoptosis (VERY HIGH YIELD)
| Feature | Necrosis | Apoptosis |
|---|
| Cause | Hypoxia, toxins, severe injury | Physiologic or pathologic signals |
| Cell size | Swells (oncosis) | Shrinks |
| Nucleus | Karyolysis, karyorrhexis, pyknosis | Fragmentation (ladder pattern on gel) |
| Membrane | Disrupted | Intact (forms blebs) |
| Inflammation | YES (contents spill out) | NO (phagocytosed cleanly) |
| Energy required | No | Yes (active process) |
| Mechanism | Passive, uncontrolled | Caspase-mediated (intrinsic or extrinsic) |
Types of Necrosis:
- Coagulative - most organs (heart, kidney); structure preserved, cells ghost-like (ischemia)
- Liquefactive - brain infarct; bacterial abscesses (enzymes dissolve tissue)
- Caseous - TB; soft, cheese-like; surrounded by granuloma
- Fat - breast, pancreas; saponification, chalky deposits
- Fibrinoid - vessel walls in malignant hypertension, vasculitis
- Gangrenous - limb ischemia; dry (coagulative) or wet (liquefactive with infection)
Apoptosis Mechanisms:
- Intrinsic (mitochondrial) pathway - DNA damage, growth factor withdrawal → Bcl-2 family → cytochrome c release → caspase-9 → caspase-3
- Extrinsic (death receptor) pathway - FasL/TNF binds receptor → DISC → caspase-8 → caspase-3
- Bcl-2 is anti-apoptotic (overexpressed in follicular lymphoma)
- p53 triggers apoptosis via DNA damage
Cellular Adaptations to Stress
| Adaptation | Definition | Physiologic Example | Pathologic Example |
|---|
| Hypertrophy | ↑ cell size | Uterus in pregnancy, skeletal muscle with exercise | Cardiac hypertrophy in HTN |
| Hyperplasia | ↑ cell number | Endometrium in menstrual cycle | Endometrial hyperplasia (excess estrogen) |
| Atrophy | ↓ cell size + number | Skeletal muscle in weightlessness | Disuse atrophy, denervation |
| Metaplasia | One cell type replaced by another | None | Barrett esophagus (squamous → columnar), smoker's bronchi (columnar → squamous) |
- Atrophy = ↓ protein synthesis + ↑ protein degradation (ubiquitin-proteasome pathway + autophagy)
- Metaplasia is reversible but predisposes to dysplasia/cancer
Intracellular Depositions
- Fatty change (steatosis) - liver, heart; in alcoholism, obesity, diabetes
- Cholesterol deposits - atherosclerosis, xanthomas
- Protein - Mallory bodies (alcoholic liver), Russell bodies (plasma cells)
- Glycogen - diabetes, glycogen storage diseases
- Pigments:
- Lipofuscin ("wear-and-tear" pigment) - brown, in aging cells
- Hemosiderin - iron pigment from hemoglobin degradation; hemosiderosis vs hemochromatosis
- Melanin - normal, increased in Addison disease
- Carbon - anthracosis (coal miners' lung)
Pathologic Calcification:
- Dystrophic calcification - in dead/necrotic tissue; serum Ca²⁺ NORMAL; seen in TB, atherosclerosis, dead parasites
- Metastatic calcification - in normal tissue; serum Ca²⁺ HIGH (hypercalcemia); seen in hyperparathyroidism, sarcoidosis
PART 2: INFLAMMATION & REPAIR
What is Inflammation?
A protective vascular-connective tissue response to eliminate the cause of injury, remove damaged tissue, and initiate repair. It can be harmful when excessive (sepsis, autoimmunity).
Cardinal signs (Celsus + Virchow): Rubor (redness), Calor (heat), Tumor (swelling), Dolor (pain), + Functio laesa (loss of function)
Recognition of Injury - Pattern Recognition Receptors (PRRs)
- Toll-like receptors (TLRs) - on surface and in endosomes; recognize PAMPs (microbial) and DAMPs (damaged self)
- NOD-like receptors (NLRs) - cytosolic; form the inflammasome → activates IL-1β
- PAMPs = pathogen-associated molecular patterns (e.g., LPS)
- DAMPs = damage-associated molecular patterns (e.g., leaked DNA, ATP)
Acute Inflammation - The Three Key Components
- Vasodilation (↑ blood flow → redness + heat)
- ↑ Vascular permeability (fluid leaks into tissue → swelling)
- Leukocyte emigration (mainly neutrophils)
Sequence in blood vessels:
- Vasodilation → stasis → margination → rolling → adhesion → transmigration → chemotaxis → phagocytosis
Key Molecules:
| Step | Molecules |
|---|
| Rolling | Selectins (E-selectin, P-selectin on endothelium; L-selectin on leukocytes); Sialyl-Lewis X on leukocytes |
| Adhesion | ICAM-1 (endothelium) + Integrins (LFA-1, Mac-1 on leukocytes) |
| Transmigration | PECAM-1 (CD31) |
| Chemotaxis | C5a, LTB4, IL-8, bacterial products (fMLP) |
Phagocytosis
- Recognition/Attachment - opsonins (IgG, C3b) bind to Fc receptors and CR3
- Engulfment - pseudopods form phagosome
- Killing - oxidative (myeloperoxidase-H₂O₂-halide system → HOCl) and non-oxidative (defensins, lysozyme, lactoferrin)
Leukocyte defects:
- Chediak-Higashi syndrome - defective lysosomal fusion
- Chronic Granulomatous Disease (CGD) - defective NADPH oxidase; catalase-positive organisms survive
- LAD (Leukocyte Adhesion Deficiency) - defective CD18 (integrin); delayed umbilical cord separation
Chemical Mediators of Inflammation (HIGH YIELD)
| Mediator | Source | Action |
|---|
| Histamine | Mast cells, platelets | Vasodilation, ↑ permeability (early, fast) |
| Serotonin | Platelets | ↑ Permeability |
| Prostaglandins (PGE2, PGI2) | Arachidonic acid (COX pathway) | Vasodilation, fever, pain |
| Leukotrienes (LTB4) | Arachidonic acid (LOX pathway) | LTB4: chemotaxis; LTC4/D4/E4: bronchoconstriction, ↑ permeability |
| PAF | Leukocytes, mast cells | Platelet aggregation, vasodilation |
| TNF & IL-1 | Macrophages | Fever, acute-phase response, endothelial activation |
| IL-6 | Macrophages, T cells | Acute-phase proteins (CRP, fibrinogen) |
| IL-8 (CXCL8) | Macrophages, endothelium | Neutrophil chemotaxis |
| Complement (C3a, C5a) | Plasma (liver) | C3a/C5a: anaphylatoxins; C5a: chemotaxis; C3b: opsonin; MAC: lysis |
| Bradykinin | Kinin system | Pain, vasodilation, ↑ permeability |
| Nitric oxide (NO) | Endothelium, macrophages | Vasodilation, kills microbes |
Key drug targets: Aspirin/NSAIDs block COX → ↓ PGs; Glucocorticoids block phospholipase A2 → ↓ all AA metabolites; Montelukast blocks LT receptors
Morphologic Patterns of Acute Inflammation
| Pattern | Features | Example |
|---|
| Serous | Watery, protein-poor fluid | Blister, pleuritis (viral), pericarditis |
| Fibrinous | Fibrin exudate | Fibrinous pericarditis ("bread-and-butter" appearance), lobar pneumonia |
| Suppurative/Purulent | Pus (neutrophils + liquefied debris) | Abscess, bacterial meningitis, empyema |
| Ulcer | Epithelial defect | Peptic ulcer, aphthous stomatitis |
Outcomes of Acute Inflammation
- Resolution - complete restoration (most viral infections)
- Abscess formation - walling off of pus
- Fibrosis/Scarring - if tissue cannot regenerate
- Progression to chronic inflammation
Chronic Inflammation
- Duration: weeks-months; mononuclear cells predominate (lymphocytes, plasma cells, macrophages)
- Causes: persistent infection (TB, syphilis), autoimmune, prolonged exposure to toxic agents
- Key cells: Macrophages (most important), Lymphocytes (T and B), Plasma cells, Eosinophils (parasites, allergy), Mast cells
Macrophages in chronic inflammation:
- Activated by IFN-γ (from T cells) → produce TNF, IL-12, ROS, lysosomal enzymes
- Form the backbone of granulomas
Granulomatous Inflammation:
- Special form of chronic inflammation
- Core: Epithelioid macrophages + Langhans giant cells (horseshoe-shaped nuclei) + CD4⁺ T cells
- Causes:
- Infectious: TB (caseous necrosis, AFB positive), leprosy, syphilis, cat-scratch disease
- Non-infectious: Sarcoidosis (non-caseating!), Crohn disease, berylliosis, foreign body reaction
Tip: "Naked granulomas" = sarcoidosis (no caseation). "Caseating granulomas" = TB.
Systemic Effects of Inflammation - Acute Phase Response
- Fever - IL-1, TNF, IL-6 → COX in hypothalamus → ↑ PGE2 → set point rises
- Acute-phase proteins (from liver, induced by IL-6): CRP, fibrinogen, serum amyloid A, haptoglobin (↑); albumin and transferrin (↓)
- Leukocytosis:
- Bacterial infections → neutrophilia
- Viral infections → lymphocytosis
- Parasites/allergy → eosinophilia
- Septic shock - systemic TNF/IL-1 overproduction → ↓ BP, DIC, multi-organ failure
Tissue Repair
- Labile cells (always dividing) - GI epithelium, skin, bone marrow → best regeneration
- Stable cells (quiescent; can re-enter cycle) - liver, kidney, fibroblasts → good regeneration
- Permanent cells (cannot divide) - neurons, cardiac muscle, skeletal muscle → replaced by scar
Steps in Scar Formation:
- Granulation tissue forms (fibroblasts + new capillaries)
- Angiogenesis (VEGF, FGF)
- Fibroblast activation → collagen deposition (TGF-β is the key cytokine)
- Remodeling (MMPs degrade collagen; balance of synthesis vs degradation)
Factors impairing healing: Infection, malnutrition (vitamin C deficiency → ↓ collagen), poor blood supply, DM, corticosteroids, foreign bodies, poor surgical technique
PART 3: NEOPLASIA
Definitions
- Neoplasia - abnormal, uncontrolled, purposeless proliferation of cells; persists after stimulus removed
- Tumor - a mass formed by neoplastic cells (also means swelling)
- Benign - grows locally, does NOT invade or metastasize; well-differentiated
- Malignant - can invade locally AND metastasize; varying differentiation
Nomenclature (HIGH YIELD)
| Cell Origin | Benign | Malignant |
|---|
| Epithelium (squamous) | Squamous papilloma | Squamous cell carcinoma |
| Epithelium (gland) | Adenoma | Adenocarcinoma |
| Fibrous tissue | Fibroma | Fibrosarcoma |
| Smooth muscle | Leiomyoma | Leiomyosarcoma |
| Cartilage | Chondroma | Chondrosarcoma |
| Bone | Osteoma | Osteosarcoma |
| Lymphoid tissue | - | Lymphoma |
| Melanocytes | Melanocytic nevus | Melanoma |
| Hematopoietic | - | Leukemia |
| Mixed (epithelial + mesenchymal) | - | Carcinosarcoma |
Special terms:
- Hamartoma - disorganized mass of native tissue (e.g., pulmonary hamartoma)
- Choristoma - normal tissue in wrong location (e.g., gastric mucosa in Meckel's diverticulum)
- Teratoma - all 3 germ layers; mature (benign) vs immature (malignant)
Benign vs Malignant Tumors
| Feature | Benign | Malignant |
|---|
| Differentiation | Well-differentiated | Variable; may be anaplastic |
| Mitoses | Rare, normal | Frequent, abnormal |
| Nuclear changes | Normal | Pleomorphism, ↑ N:C ratio, prominent nucleoli |
| Growth rate | Slow | Fast |
| Local invasion | Expansile, encapsulated | Infiltrative, NOT encapsulated |
| Metastasis | NO | YES (hallmark of malignancy) |
| Necrosis | Rare | Common |
Anaplasia features: Pleomorphism, hyperchromatism, giant tumor cells, abnormal mitoses, prominent nucleoli, loss of polarity
Carcinogenesis: A Multistep Process
- Cancer is clonal in origin (from a single mutated cell)
- Accumulation of multiple somatic mutations over time
- Key steps: Initiation → Promotion → Progression → Malignant transformation
Hallmarks of Cancer (Hanahan & Weinberg - MUST KNOW)
- Self-sufficiency in growth signals - oncogenes mimic growth factor signaling (RAS, MYC)
- Insensitivity to growth-inhibitory signals - loss of tumor suppressors (RB, TP53)
- Evasion of apoptosis - overexpression of Bcl-2; loss of p53
- Limitless replicative potential (immortality) - telomerase activation
- Sustained angiogenesis - VEGF, FGF; "angiogenic switch"
- Invasion and metastasis - ↓ E-cadherin; ↑ metalloproteinases (MMPs); epithelial-mesenchymal transition (EMT)
- Evasion of immune surveillance - PD-L1 expression, loss of MHC-I
- Altered cellular metabolism (Warburg effect) - aerobic glycolysis even in presence of O₂
- Tumor-promoting inflammation
- Genome instability and mutation
Key Cancer Genes
Proto-oncogenes → Oncogenes (gain-of-function mutations):
| Oncogene | Mechanism | Cancer |
|---|
| RAS | Point mutation (GTPase stays "on") | Colon, pancreas, lung |
| MYC | Amplification/translocation | Burkitt lymphoma (t(8;14)) |
| HER2/NEU (ERBB2) | Amplification | Breast cancer |
| BCR-ABL | Translocation t(9;22) Philadelphia chromosome | CML |
| RET | Point mutation | MEN2, medullary thyroid CA |
| EGFR | Mutation/amplification | Lung, colon |
Tumor Suppressor Genes (loss-of-function, "two-hit hypothesis"):
| Gene | Function | Cancer |
|---|
| RB | Cell cycle brake (G1→S checkpoint) | Retinoblastoma, osteosarcoma |
| TP53 | "Guardian of genome" - DNA repair, apoptosis, cell cycle arrest | Li-Fraumeni syndrome; most human cancers |
| APC | WNT signaling suppressor | FAP, colon cancer |
| BRCA1/2 | DNA repair (homologous recombination) | Breast, ovarian cancer |
| CDKN2A (p16) | CDK4 inhibitor | Melanoma, pancreatic cancer |
| VHL | Regulates HIF | Renal cell carcinoma |
| WT1 | Transcription factor | Wilms tumor |
Knudson "Two-Hit" Hypothesis: Both alleles of a TSG must be inactivated - one inherited mutation + one somatic mutation.
Tumor Invasion and Metastasis
Steps in metastasis:
- Local invasion (loss of E-cadherin, ↑ MMPs, EMT)
- Intravasation into blood/lymphatics
- Survival in circulation (immune evasion)
- Extravasation
- Colonization of new site (organ-specific "seed and soil" hypothesis - Paget)
Routes of metastasis:
- Hematogenous - sarcomas; liver and lung most common sites
- Lymphatic - carcinomas; regional nodes first
- Seeding of body cavities - colon/ovary → peritoneum (Krukenberg tumor: gastric ca → bilateral ovaries)
Carcinogenic Agents
| Type | Examples | Cancer |
|---|
| Chemical carcinogens | Polycyclic aromatic hydrocarbons (tobacco) | Lung, bladder |
| Aflatoxin B1 | Hepatocellular carcinoma |
| Benzene | Leukemia |
| Vinyl chloride | Angiosarcoma of liver |
| Nitrosamines | Gastric, esophageal |
| Arsenic | Skin, lung |
| Radiation | UV light (→ pyrimidine dimers, XPC mutations) | Melanoma, BCC, SCC |
| Ionizing radiation | Leukemia, thyroid CA |
| Viral | HPV 16/18 (E6→p53, E7→RB) | Cervical, oropharyngeal |
| EBV | Burkitt lymphoma, Hodgkin lymphoma, NPC |
| HBV/HCV | Hepatocellular carcinoma |
| HTLV-1 | Adult T-cell leukemia/lymphoma |
| HHV-8 (KSHV) | Kaposi sarcoma |
| Helicobacter pylori | Chronic gastritis | Gastric adenocarcinoma, MALT lymphoma |
Tumor Immunology
- Tumor antigens:
- Neoantigens (mutated proteins) - most immunogenic
- Overexpressed normal proteins (HER2, CEA)
- Cancer-testis antigens (MAGE, NY-ESO-1)
- Viral antigens (EBV, HPV)
- Immune surveillance: CD8⁺ CTLs are primary killers; NK cells also important
- Immune evasion: ↓ MHC-I expression, PD-L1/PD-1 axis, CTLA-4, TGF-β
- Checkpoint inhibitors (anti-PD-1, anti-CTLA-4) harness this for cancer therapy
Tumor Effects on Host
- Local effects - compression, obstruction (e.g., bowel obstruction, hydronephrosis)
- Cachexia - wasting; TNF (cachectin), IL-1, IFN-γ reduce appetite and increase catabolism
- Paraneoplastic syndromes (tumor products that act at distant sites):
| Syndrome | Mechanism | Tumor |
|---|
| Hypercalcemia | PTHrP secretion | Squamous cell carcinoma, breast, renal |
| SIADH | ADH-like peptides | Small cell lung cancer |
| Cushing syndrome | ACTH-like peptides | Small cell lung cancer |
| Polycythemia | EPO | Renal cell carcinoma, hepatocellular |
| Migratory thrombophlebitis (Trousseau sign) | Mucin activates clotting | Pancreatic, GI cancers |
| Eaton-Lambert | Anti-VGCC antibodies | Small cell lung cancer |
RAPID REVIEW TABLE - Key Buzzwords
| High-Yield Fact | Answer |
|---|
| Most common cause of cell injury | Hypoxia/Ischemia |
| "Guardian of the genome" | p53 (TP53) |
| Anti-apoptotic gene overexpressed in follicular lymphoma | Bcl-2 (t(14;18)) |
| Caseous necrosis + granuloma | TB |
| Non-caseating granuloma | Sarcoidosis |
| Warm autoimmune hemolysis mediator | IgG |
| "Bread-and-butter" pericarditis | Fibrinous inflammation |
| Defective NADPH oxidase | Chronic Granulomatous Disease |
| Philadelphia chromosome t(9;22) | CML (BCR-ABL) |
| t(8;14) MYC translocation | Burkitt lymphoma |
| Two-hit hypothesis | Knudson; applies to TSGs like RB |
| Seed and soil hypothesis | Paget; organ tropism in metastasis |
| Hallmark of malignancy | Metastasis |
| Warburg effect | Aerobic glycolysis in tumors |
| HPV E6 | Degrades p53 |
| HPV E7 | Inactivates RB |
| Wear-and-tear pigment | Lipofuscin |
| Dystrophic vs metastatic calcification | Normal Ca²⁺ vs High Ca²⁺ |
Source: Robbins Basic Pathology (Robbins Pathology) and Robbins, Cotran & Kumar Pathologic Basis of Disease - General Pathology chapters on Cell Injury, Inflammation & Repair, and Neoplasia.
These notes cover everything you need for General Pathology exam prep. Let me know which topic you want to go deeper on - for example:
- More MCQ-style practice questions
- Specific mechanisms in more detail (e.g., apoptosis pathways, complement cascade)
- Systemic pathology topics (CVS, respiratory, GI, hematology, etc.)
- Any specific area you're uncertain about